Dr Peter Jones wrote in an article that "cryoprecipitate is now the product of choice in major surgery, allowing the potent but antigenic animal fractions and expensive human concentrate to be reserved for major complications, the emergency treatment of patients with FVIII inhibitors, or, in the case of concentrate, for prophylaxis."